Report Company Directory

Erajaya Swasembada

• Regional Morning Meeting Notes: Thursday, April 2, 2026 by UOB
• Erajaya Swasembada (ERAA IJ) - 2025: Full-Year Earnings Better Than Expected by UOB
• Indonesia Daily - Thursday, April 2, 2026 by UOB
• Anchor Report: Indonesia Consumer - Fight for relevance by Nomura Research
• Regional Morning Meeting Notes: Tuesday, January 06, 2026 by UOB
• Erajaya Swasembada (ERAA IJ) - Strong November Performance Supports 2H25 Momentum by UOB
• Indonesia Daily - Tuesday, January 6, 2026 by UOB
• インドネシア株ストラテジー - 26年の見通し by Nomura Research
• Anchor Report: Indonesia Equity Strategy - Turning over a new leaf by Nomura Research
• Quick Note - Indonesia Retailers - 3Q25 review: Lackluster quarter, as expected by Nomura Research

Eramet

• Eramet : Excellent 2017 results, upgrading our shadow rating. New strategic plan. by Oddo BHF
• Eramet : Excellents résultats 2017, upgrade de notre rating estimé. Nouveau plan stratégique. by Oddo BHF
• Analyse court terme - ERAMET : La moyenne mobile, haussière, confirme notre avis. by Day By Day
• Short term view - ERAMET : The rising moving average confirms our opinion. by Day By Day

Eramet SA

• At a crossroads by BNP Paribas
• Credit Morning 03/10/2026 by Oddo BHF
• Morning Crédit 10/03/2026 by Oddo BHF
• ERAMET S.A.: Update following downgrade to B2 by Moody's Investors Service
• Eramet : Informations relatives au nombre total de droits de vote et d’actions au 28 février 2026 by GlobeNewsWire
• ALUMINIUM, STEEL EU, STEEL CHINA NPC, LITHIUM, BUILDING MATS by BNP Paribas
• Credit Morning 03/04/2026 by Oddo BHF
• Morning Crédit 04/03/2026 by Oddo BHF
• Moody's Ratings downgrades Eramet to B2; changes outlook to stable from negative by Moody's Investors Service
• ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 03/03/2026 by Oddo BHF

ERANSUS INV XXI SICAV SA

ERASCA INC

• Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results by GlobeNewsWire
• Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau by GlobeNewsWire
• Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat by GlobeNewsWire
• Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001 by GlobeNewsWire
• Erasca to Present at Upcoming Conferences in February by GlobeNewsWire
• US Thematic Research - Private Healthcare Outlook Series "Therapeutics: We..." by UBS AG
• Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares by GlobeNewsWire
• Erasca Announces Pricing of Upsized Public Offering of Common Stock by GlobeNewsWire
• Erasca Announces Proposed Public Offering of $150 Million of Common Stock by GlobeNewsWire
• Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones by GlobeNewsWire